SHA:600161 Revenue

Beijing Tiantan Biological Products had revenue of 1.32B CNY in the quarter ending March 31, 2025, with 7.84% growth. This brings the company's revenue in the last twelve months to 6.13B, up 19.91% year-over-year. In the year 2024, Beijing Tiantan Biological Products had annual revenue of 6.03B with 16.44% growth.

Revenue (ttm)

6.13B

Revenue Growth

+19.91%

P/S Ratio

6.73

Revenue / Employee

1.16M

Employees

5,298

Market Cap

41.23B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.03B	851.42M	16.44%
Dec 31, 2023	5.18B	919.14M	21.57%
Dec 31, 2022	4.26B	149.15M	3.63%
Dec 31, 2021	4.11B	666.56M	19.35%
Dec 31, 2020	3.45B	163.74M	4.99%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Shanghai United Imaging Healthcare	10.30B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.03B

Revenue Rankings